Loading…
Preoperative radiotherapy for esophageal carcinoma
The existing randomized evidence has failed to conclusively demonstrate the benefit or otherwise of preoperative radiotherapy in treating patients with potentially resectable esophageal carcinoma. This meta-analysis aimed to assess whether there is benefit from adding radiotherapy prior to surgery a...
Saved in:
| Published in: | Cochrane database of systematic reviews 2005-10, Vol.2005 (4), p.CD001799-CD001799 |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4712-2134a840f4f764f75a0f53dfa4282e6bb76e601662d42322a9f981d0f9e8f3303 |
|---|---|
| cites | |
| container_end_page | CD001799 |
| container_issue | 4 |
| container_start_page | CD001799 |
| container_title | Cochrane database of systematic reviews |
| container_volume | 2005 |
| creator | Arnott, S J Duncan, W Gignoux, M Hansen, H S Launois, B Nygaard, K Parmar, M K B Rousell, A Spilopoulos, G Stewart, G Tierney, J F Wang, M Rhugang, Z |
| description | The existing randomized evidence has failed to conclusively demonstrate the benefit or otherwise of preoperative radiotherapy in treating patients with potentially resectable esophageal carcinoma.
This meta-analysis aimed to assess whether there is benefit from adding radiotherapy prior to surgery and whether or not any pre-defined patient subgroups benefit more or less from preoperative radiotherapy
MEDLINE and CancerLit searches were supplemented by information from trial registers and by hand searching relevant meeting proceedings and by discussion with relevant trialists, organisations and industry. The search strategy was run again in MEDLINE, EMBASE and the Cochrane Library on 30th April 2001, two years after original publication. No new trials were found. The search strategy was re-run August 2002 and August 2003 on MEDLINE, EMBASE , CancerLit and The Cochrane Library, and July 2004 and 2005 on MEDLINE, EMBASE and the Cochrane Library. No new relevant trials were identified on any of these occasions.
Trials were eligible for inclusion in this meta-analysis provided they randomized patients with potentially resectable carcinoma of the esophagus (of any histological type) to receive radiotherapy or no radiotherapy prior to surgery. Trials must have used a randomization method which precluded prior knowledge of treatment assignment and completed accrual by December 1993, to ensure sufficient follow-up by the time of the first analysis (September 1995).
A quantitative meta-analysis using updated data from individual patients from all properly randomized trials (published or unpublished) comprising 1147 patients (971 deaths) from five randomized trials. This approach was used to assess whether preoperative radiotherapy improves overall survival and whether it is differentially effective in patients defined by age, sex and tumour location.
With a median follow-up of 9 years, in a group patients with mostly squamous carcinomas, the hazard ratio (HR) of 0.89 (95% CI 0.78-1.01) suggests an overall reduction in the risk of death of 11% and an absolute survival benefit of 3% at 2 years and 4% at 5 years. This result is not conventionally statistically significant (p=0.062). No clear differences in the size of the effect by sex, age or tumor location were apparent.
Based on existing trials, there was no clear evidence that preoperative radiotherapy improves the survival of patients with potentially resectable esophageal cancer. These results indicate that if su |
| doi_str_mv | 10.1002/14651858.CD001799.pub2 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8407511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68704257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4712-2134a840f4f764f75a0f53dfa4282e6bb76e601662d42322a9f981d0f9e8f3303</originalsourceid><addsrcrecordid>eNpVkEtLAzEQx4Mgtla_QtmTt615bR4XQeoTCnpQ8Bamu0kb2d2sybbQb2_AB3oYhuE__H7MIDQneEEwppeEi4qoSi2WNxgTqfVi2K3pEZrmQJdcs7cJOk3pHWOmCVEnaEIEZRVVYoroc7RhsBFGv7dFhMaHcZvH4VC4EAubwrCFjYW2qCHWvg8dnKFjB22y5999hl7vbl-WD-Xq6f5xeb0qay4JLSlhHBTHjjspclWAXcUaB5wqasV6LYUVmAhBG04ZpaCdVqTBTlvlGMNshq6-uPmazja17ccIrRmi7yAeTABv_ie935pN2JsslRUhGXDxDYjhY2fTaDqfatu20NuwS0YoiTmtZF6c_zX9Kn7exD4BGupqSQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68704257</pqid></control><display><type>article</type><title>Preoperative radiotherapy for esophageal carcinoma</title><source>Alma/SFX Local Collection</source><creator>Arnott, S J ; Duncan, W ; Gignoux, M ; Hansen, H S ; Launois, B ; Nygaard, K ; Parmar, M K B ; Rousell, A ; Spilopoulos, G ; Stewart, G ; Tierney, J F ; Wang, M ; Rhugang, Z</creator><creatorcontrib>Arnott, S J ; Duncan, W ; Gignoux, M ; Hansen, H S ; Launois, B ; Nygaard, K ; Parmar, M K B ; Rousell, A ; Spilopoulos, G ; Stewart, G ; Tierney, J F ; Wang, M ; Rhugang, Z ; Oeosphageal Cancer Collaborative Group</creatorcontrib><description>The existing randomized evidence has failed to conclusively demonstrate the benefit or otherwise of preoperative radiotherapy in treating patients with potentially resectable esophageal carcinoma.
This meta-analysis aimed to assess whether there is benefit from adding radiotherapy prior to surgery and whether or not any pre-defined patient subgroups benefit more or less from preoperative radiotherapy
MEDLINE and CancerLit searches were supplemented by information from trial registers and by hand searching relevant meeting proceedings and by discussion with relevant trialists, organisations and industry. The search strategy was run again in MEDLINE, EMBASE and the Cochrane Library on 30th April 2001, two years after original publication. No new trials were found. The search strategy was re-run August 2002 and August 2003 on MEDLINE, EMBASE , CancerLit and The Cochrane Library, and July 2004 and 2005 on MEDLINE, EMBASE and the Cochrane Library. No new relevant trials were identified on any of these occasions.
Trials were eligible for inclusion in this meta-analysis provided they randomized patients with potentially resectable carcinoma of the esophagus (of any histological type) to receive radiotherapy or no radiotherapy prior to surgery. Trials must have used a randomization method which precluded prior knowledge of treatment assignment and completed accrual by December 1993, to ensure sufficient follow-up by the time of the first analysis (September 1995).
A quantitative meta-analysis using updated data from individual patients from all properly randomized trials (published or unpublished) comprising 1147 patients (971 deaths) from five randomized trials. This approach was used to assess whether preoperative radiotherapy improves overall survival and whether it is differentially effective in patients defined by age, sex and tumour location.
With a median follow-up of 9 years, in a group patients with mostly squamous carcinomas, the hazard ratio (HR) of 0.89 (95% CI 0.78-1.01) suggests an overall reduction in the risk of death of 11% and an absolute survival benefit of 3% at 2 years and 4% at 5 years. This result is not conventionally statistically significant (p=0.062). No clear differences in the size of the effect by sex, age or tumor location were apparent.
Based on existing trials, there was no clear evidence that preoperative radiotherapy improves the survival of patients with potentially resectable esophageal cancer. These results indicate that if such preoperative radiotherapy regimens do improve survival, then the effect is likely to be modest with an absolute improvement in survival of around 3 to 4%. Trials or a meta-analysis of around 2000 patients (90% power, 5% significance level) would be needed to reliably detect such an improvement (from 15 to 20%).</description><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD001799.pub2</identifier><identifier>PMID: 16235286</identifier><language>eng</language><publisher>England: John Wiley & Sons, Ltd</publisher><subject>Cancer ; Esophageal Neoplasms - radiotherapy ; Esophageal Neoplasms - surgery ; Gastroenterology & hepatology ; Humans ; OESOPHAGUS ; Preoperative Care ; Radiotherapy, Adjuvant ; Randomized Controlled Trials as Topic</subject><ispartof>Cochrane database of systematic reviews, 2005-10, Vol.2005 (4), p.CD001799-CD001799</ispartof><rights>Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4712-2134a840f4f764f75a0f53dfa4282e6bb76e601662d42322a9f981d0f9e8f3303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16235286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arnott, S J</creatorcontrib><creatorcontrib>Duncan, W</creatorcontrib><creatorcontrib>Gignoux, M</creatorcontrib><creatorcontrib>Hansen, H S</creatorcontrib><creatorcontrib>Launois, B</creatorcontrib><creatorcontrib>Nygaard, K</creatorcontrib><creatorcontrib>Parmar, M K B</creatorcontrib><creatorcontrib>Rousell, A</creatorcontrib><creatorcontrib>Spilopoulos, G</creatorcontrib><creatorcontrib>Stewart, G</creatorcontrib><creatorcontrib>Tierney, J F</creatorcontrib><creatorcontrib>Wang, M</creatorcontrib><creatorcontrib>Rhugang, Z</creatorcontrib><creatorcontrib>Oeosphageal Cancer Collaborative Group</creatorcontrib><title>Preoperative radiotherapy for esophageal carcinoma</title><title>Cochrane database of systematic reviews</title><addtitle>Cochrane Database Syst Rev</addtitle><description>The existing randomized evidence has failed to conclusively demonstrate the benefit or otherwise of preoperative radiotherapy in treating patients with potentially resectable esophageal carcinoma.
This meta-analysis aimed to assess whether there is benefit from adding radiotherapy prior to surgery and whether or not any pre-defined patient subgroups benefit more or less from preoperative radiotherapy
MEDLINE and CancerLit searches were supplemented by information from trial registers and by hand searching relevant meeting proceedings and by discussion with relevant trialists, organisations and industry. The search strategy was run again in MEDLINE, EMBASE and the Cochrane Library on 30th April 2001, two years after original publication. No new trials were found. The search strategy was re-run August 2002 and August 2003 on MEDLINE, EMBASE , CancerLit and The Cochrane Library, and July 2004 and 2005 on MEDLINE, EMBASE and the Cochrane Library. No new relevant trials were identified on any of these occasions.
Trials were eligible for inclusion in this meta-analysis provided they randomized patients with potentially resectable carcinoma of the esophagus (of any histological type) to receive radiotherapy or no radiotherapy prior to surgery. Trials must have used a randomization method which precluded prior knowledge of treatment assignment and completed accrual by December 1993, to ensure sufficient follow-up by the time of the first analysis (September 1995).
A quantitative meta-analysis using updated data from individual patients from all properly randomized trials (published or unpublished) comprising 1147 patients (971 deaths) from five randomized trials. This approach was used to assess whether preoperative radiotherapy improves overall survival and whether it is differentially effective in patients defined by age, sex and tumour location.
With a median follow-up of 9 years, in a group patients with mostly squamous carcinomas, the hazard ratio (HR) of 0.89 (95% CI 0.78-1.01) suggests an overall reduction in the risk of death of 11% and an absolute survival benefit of 3% at 2 years and 4% at 5 years. This result is not conventionally statistically significant (p=0.062). No clear differences in the size of the effect by sex, age or tumor location were apparent.
Based on existing trials, there was no clear evidence that preoperative radiotherapy improves the survival of patients with potentially resectable esophageal cancer. These results indicate that if such preoperative radiotherapy regimens do improve survival, then the effect is likely to be modest with an absolute improvement in survival of around 3 to 4%. Trials or a meta-analysis of around 2000 patients (90% power, 5% significance level) would be needed to reliably detect such an improvement (from 15 to 20%).</description><subject>Cancer</subject><subject>Esophageal Neoplasms - radiotherapy</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Gastroenterology & hepatology</subject><subject>Humans</subject><subject>OESOPHAGUS</subject><subject>Preoperative Care</subject><subject>Radiotherapy, Adjuvant</subject><subject>Randomized Controlled Trials as Topic</subject><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEQx4Mgtla_QtmTt615bR4XQeoTCnpQ8Bamu0kb2d2sybbQb2_AB3oYhuE__H7MIDQneEEwppeEi4qoSi2WNxgTqfVi2K3pEZrmQJdcs7cJOk3pHWOmCVEnaEIEZRVVYoroc7RhsBFGv7dFhMaHcZvH4VC4EAubwrCFjYW2qCHWvg8dnKFjB22y5999hl7vbl-WD-Xq6f5xeb0qay4JLSlhHBTHjjspclWAXcUaB5wqasV6LYUVmAhBG04ZpaCdVqTBTlvlGMNshq6-uPmazja17ccIrRmi7yAeTABv_ie935pN2JsslRUhGXDxDYjhY2fTaDqfatu20NuwS0YoiTmtZF6c_zX9Kn7exD4BGupqSQ</recordid><startdate>20051019</startdate><enddate>20051019</enddate><creator>Arnott, S J</creator><creator>Duncan, W</creator><creator>Gignoux, M</creator><creator>Hansen, H S</creator><creator>Launois, B</creator><creator>Nygaard, K</creator><creator>Parmar, M K B</creator><creator>Rousell, A</creator><creator>Spilopoulos, G</creator><creator>Stewart, G</creator><creator>Tierney, J F</creator><creator>Wang, M</creator><creator>Rhugang, Z</creator><general>John Wiley & Sons, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20051019</creationdate><title>Preoperative radiotherapy for esophageal carcinoma</title><author>Arnott, S J ; Duncan, W ; Gignoux, M ; Hansen, H S ; Launois, B ; Nygaard, K ; Parmar, M K B ; Rousell, A ; Spilopoulos, G ; Stewart, G ; Tierney, J F ; Wang, M ; Rhugang, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4712-2134a840f4f764f75a0f53dfa4282e6bb76e601662d42322a9f981d0f9e8f3303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Cancer</topic><topic>Esophageal Neoplasms - radiotherapy</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Gastroenterology & hepatology</topic><topic>Humans</topic><topic>OESOPHAGUS</topic><topic>Preoperative Care</topic><topic>Radiotherapy, Adjuvant</topic><topic>Randomized Controlled Trials as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arnott, S J</creatorcontrib><creatorcontrib>Duncan, W</creatorcontrib><creatorcontrib>Gignoux, M</creatorcontrib><creatorcontrib>Hansen, H S</creatorcontrib><creatorcontrib>Launois, B</creatorcontrib><creatorcontrib>Nygaard, K</creatorcontrib><creatorcontrib>Parmar, M K B</creatorcontrib><creatorcontrib>Rousell, A</creatorcontrib><creatorcontrib>Spilopoulos, G</creatorcontrib><creatorcontrib>Stewart, G</creatorcontrib><creatorcontrib>Tierney, J F</creatorcontrib><creatorcontrib>Wang, M</creatorcontrib><creatorcontrib>Rhugang, Z</creatorcontrib><creatorcontrib>Oeosphageal Cancer Collaborative Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arnott, S J</au><au>Duncan, W</au><au>Gignoux, M</au><au>Hansen, H S</au><au>Launois, B</au><au>Nygaard, K</au><au>Parmar, M K B</au><au>Rousell, A</au><au>Spilopoulos, G</au><au>Stewart, G</au><au>Tierney, J F</au><au>Wang, M</au><au>Rhugang, Z</au><aucorp>Oeosphageal Cancer Collaborative Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preoperative radiotherapy for esophageal carcinoma</atitle><jtitle>Cochrane database of systematic reviews</jtitle><addtitle>Cochrane Database Syst Rev</addtitle><date>2005-10-19</date><risdate>2005</risdate><volume>2005</volume><issue>4</issue><spage>CD001799</spage><epage>CD001799</epage><pages>CD001799-CD001799</pages><eissn>1469-493X</eissn><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>ObjectType-Review-1</notes><notes>ObjectType-Article-3</notes><notes>ObjectType-Undefined-4</notes><abstract>The existing randomized evidence has failed to conclusively demonstrate the benefit or otherwise of preoperative radiotherapy in treating patients with potentially resectable esophageal carcinoma.
This meta-analysis aimed to assess whether there is benefit from adding radiotherapy prior to surgery and whether or not any pre-defined patient subgroups benefit more or less from preoperative radiotherapy
MEDLINE and CancerLit searches were supplemented by information from trial registers and by hand searching relevant meeting proceedings and by discussion with relevant trialists, organisations and industry. The search strategy was run again in MEDLINE, EMBASE and the Cochrane Library on 30th April 2001, two years after original publication. No new trials were found. The search strategy was re-run August 2002 and August 2003 on MEDLINE, EMBASE , CancerLit and The Cochrane Library, and July 2004 and 2005 on MEDLINE, EMBASE and the Cochrane Library. No new relevant trials were identified on any of these occasions.
Trials were eligible for inclusion in this meta-analysis provided they randomized patients with potentially resectable carcinoma of the esophagus (of any histological type) to receive radiotherapy or no radiotherapy prior to surgery. Trials must have used a randomization method which precluded prior knowledge of treatment assignment and completed accrual by December 1993, to ensure sufficient follow-up by the time of the first analysis (September 1995).
A quantitative meta-analysis using updated data from individual patients from all properly randomized trials (published or unpublished) comprising 1147 patients (971 deaths) from five randomized trials. This approach was used to assess whether preoperative radiotherapy improves overall survival and whether it is differentially effective in patients defined by age, sex and tumour location.
With a median follow-up of 9 years, in a group patients with mostly squamous carcinomas, the hazard ratio (HR) of 0.89 (95% CI 0.78-1.01) suggests an overall reduction in the risk of death of 11% and an absolute survival benefit of 3% at 2 years and 4% at 5 years. This result is not conventionally statistically significant (p=0.062). No clear differences in the size of the effect by sex, age or tumor location were apparent.
Based on existing trials, there was no clear evidence that preoperative radiotherapy improves the survival of patients with potentially resectable esophageal cancer. These results indicate that if such preoperative radiotherapy regimens do improve survival, then the effect is likely to be modest with an absolute improvement in survival of around 3 to 4%. Trials or a meta-analysis of around 2000 patients (90% power, 5% significance level) would be needed to reliably detect such an improvement (from 15 to 20%).</abstract><cop>England</cop><pub>John Wiley & Sons, Ltd</pub><pmid>16235286</pmid><doi>10.1002/14651858.CD001799.pub2</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1469-493X |
| ispartof | Cochrane database of systematic reviews, 2005-10, Vol.2005 (4), p.CD001799-CD001799 |
| issn | 1469-493X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8407511 |
| source | Alma/SFX Local Collection |
| subjects | Cancer Esophageal Neoplasms - radiotherapy Esophageal Neoplasms - surgery Gastroenterology & hepatology Humans OESOPHAGUS Preoperative Care Radiotherapy, Adjuvant Randomized Controlled Trials as Topic |
| title | Preoperative radiotherapy for esophageal carcinoma |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T02%3A26%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preoperative%20radiotherapy%20for%20esophageal%20carcinoma&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=Arnott,%20S%20J&rft.aucorp=Oeosphageal%20Cancer%20Collaborative%20Group&rft.date=2005-10-19&rft.volume=2005&rft.issue=4&rft.spage=CD001799&rft.epage=CD001799&rft.pages=CD001799-CD001799&rft.eissn=1469-493X&rft_id=info:doi/10.1002/14651858.CD001799.pub2&rft_dat=%3Cproquest_pubme%3E68704257%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4712-2134a840f4f764f75a0f53dfa4282e6bb76e601662d42322a9f981d0f9e8f3303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68704257&rft_id=info:pmid/16235286&rfr_iscdi=true |